Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin saturation; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. In addition, the company offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, and handheld capnograph and capnometer devices; and O3 regional oximetry for tissue oxygen saturation measurement. Further, it provides Patient SafetyNet, a surveillance, remote monitoring, and clinician notification solution; MyView, a wireless presence-detection system; and connectivity devices. The company provides its products directly, as well as through distributors and original equipment manufacturers partners to hospitals, emergency medical service providers, physician offices, veterinarians, long term care facilities, and consumers. Masimo Corporation has a strategic partnership with NU Hospitals. The company was founded in 1989 and is headquartered in Irvine, California.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:MASI
Previous Symbol
CUSIP57479510
Phone949-297-7000
Debt
Debt-to-Equity RatioN/A
Current Ratio5.12
Quick Ratio4.48
Price-To-Earnings
Trailing P/E Ratio44.25
Forward P/E Ratio37.13
P/E Growth2.61
Sales & Book Value
Annual Sales$798.11 million
Price / Sales7.20
Cash Flow$2.9663 per share
Price / Cash36.55
Book Value$17.22 per share
Price / Book6.30
Profitability
EPS (Most Recent Fiscal Year)$2.45
Net Income$131.61 million
Net Margins17.08%
Return on Equity20.29%
Return on Assets16.44%
Miscellaneous
Employees1,400
Outstanding Shares53,000,000
Market Cap$5.89 billion
OptionableOptionable
Masimo (NASDAQ:MASI) Frequently Asked Questions
What is Masimo's stock symbol?
Masimo trades on the NASDAQ under the ticker symbol "MASI."
How were Masimo's earnings last quarter?
Masimo Co. (NASDAQ:MASI) issued its quarterly earnings results on Wednesday, October, 31st. The medical equipment provider reported $0.71 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.69 by $0.02. The medical equipment provider earned $210.58 million during the quarter, compared to the consensus estimate of $207.62 million. Masimo had a return on equity of 20.29% and a net margin of 17.08%. The business's quarterly revenue was up 8.9% on a year-over-year basis. During the same period in the previous year, the business earned $0.56 EPS. View Masimo's Earnings History.
When is Masimo's next earnings date?
What guidance has Masimo issued on next quarter's earnings?
Masimo issued an update on its FY18 earnings guidance on Wednesday, October, 31st. The company provided EPS guidance of $2.92 from $2.90 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.91. The company issued revenue guidance of $854 million from $850 million, compared to the consensus revenue estimate of $851.38 million.Masimo also updated its FY 2018 guidance to $2.92-2.92 EPS.
What price target have analysts set for MASI?
5 brokerages have issued twelve-month target prices for Masimo's shares. Their predictions range from $97.00 to $145.00. On average, they anticipate Masimo's stock price to reach $115.50 in the next year. This suggests a possible upside of 6.1% from the stock's current price. View Analyst Price Targets for Masimo.
What is the consensus analysts' recommendation for Masimo?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Masimo in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Masimo.
Has Masimo been receiving favorable news coverage?
Media stories about MASI stock have been trending positive on Wednesday, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Masimo earned a media sentiment score of 2.6 on InfoTrie's scale. They also gave headlines about the medical equipment provider a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the next few days.
Who are some of Masimo's key competitors?
Some companies that are related to Masimo include Varian Medical Systems (VAR), SONOVA Hldg AG/ADR (SONVY), LivaNova (LIVN), GETINGE AB/ADR (GNGBY), CONMED (CNMD), NxStage Medical (NXTM), AxoGen (AXGN), Natus Medical (BABY), Viewray (VRAY), Cutera (CUTR), Electrocore (ECOR), BioLife Solutions (BLFS), Rockwell Medical (RMTI), Semler Scientific (SMLR) and Fonar (FONR).
Who are Masimo's key executives?
Masimo's management team includes the folowing people:
- Mr. Micah Young, Exec. VP of Fin. & CFO (Age 39)
- Mr. Jon Coleman, Pres of Worldwide Sales, Professional Services & Medical Affairs (Age 54)
- Mr. Joseph E. Kiani, Founder, CEO & Chairman (Age 53)
- Mr. Anand Sampath, Chief Operating Officer (Age 52)
- Mr. David J. Van Ramshorst, Chief Accounting Officer & Sr. VP of Fin. (Age 57)
Who are Masimo's major shareholders?
Masimo's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (15.68%), FMR LLC (6.23%), American Century Companies Inc. (1.64%), MERIAN GLOBAL INVESTORS UK Ltd (1.34%), Prudential Financial Inc. (1.23%) and Victory Capital Management Inc. (1.24%). Company insiders that own Masimo stock include Anand Sampath, Bilal Muhsin, Joe E Kiani, Jon Coleman, Paul Jansen, Raad Mark De, Ramshorst David J Van, Rick Fishel, Sanford Fitch, Steven Barker, Thomas Samuel Mcclenahan and Yongsam Lee. View Institutional Ownership Trends for Masimo.
Which institutional investors are selling Masimo stock?
MASI stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Prudential Financial Inc., MERIAN GLOBAL INVESTORS UK Ltd, Wells Fargo & Company MN, JPMorgan Chase & Co., JPMorgan Chase & Co., Tributary Capital Management LLC and Capital Fund Management S.A.. Company insiders that have sold Masimo company stock in the last year include Bilal Muhsin, Joe E Kiani, Jon Coleman, Ramshorst David J Van, Sanford Fitch, Steven Barker and Yongsam Lee. View Insider Buying and Selling for Masimo.
Which institutional investors are buying Masimo stock?
MASI stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., FMR LLC, American Century Companies Inc., Ownership Capital B.V., Ownership Capital B.V., Scout Investments Inc., Victory Capital Management Inc. and Carillon Tower Advisers Inc.. View Insider Buying and Selling for Masimo.
How do I buy shares of Masimo?
Shares of MASI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Masimo's stock price today?
One share of MASI stock can currently be purchased for approximately $108.87.
How big of a company is Masimo?
Masimo has a market capitalization of $5.89 billion and generates $798.11 million in revenue each year. The medical equipment provider earns $131.61 million in net income (profit) each year or $2.45 on an earnings per share basis. Masimo employs 1,400 workers across the globe.
What is Masimo's official website?
How can I contact Masimo?
Masimo's mailing address is 52 DISCOVERY, IRVINE CA, 92618. The medical equipment provider can be reached via phone at 949-297-7000 or via email at [email protected]
MarketBeat Community Rating for Masimo (NASDAQ MASI)
MarketBeat's community ratings are surveys of what our community members think about Masimo and other stocks. Vote "Outperform" if you believe MASI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MASI will underperform the S&P 500 over the long term. You may vote once every thirty days.
